Research Article: Impact of TREM Variants on the Risk and Prognosis of Glioma in the Chinese Han Population
Abstract:
Glioma, originated from glial or precursor cells, is the main pathological subtype of brain tumors, taking up about % of primary malignant brain tumors in human. Gliomas include astrocytoma, oligodendroglioma and ependymoma. According to their clinicopathological features, gliomas can be divided into grades I–IV, thereinto, grade IV glioma is also called glioblastoma multiforme. Despite great advances in glioma diagnosis, the number of gliomas remains increasing. In , it was reported that ,, cases of brain and central nervous system (CNS) tumor were newly diagnosed in China, and the incidence rate in males was slightly higher than that in females. At present, surgery is the main treatment for glioma, and there are various treatments, such as chemotherapy, radiotherapy and immunotherapy. However, malignant brain tumors remain difficult to treat, and the overall survival rate (OS) was low. Therefore, it is urgent to study the pathogenesis of glioma. In recent years, some studies have shown that genetic factors were correlated with the risk and prognosis of glioma., The effect of genetic variants in glioma risk has attracted high attention, revealing that single nucleotide polymorphisms (SNPs) in cancer-related genes, such as TREH, ILR, CCDC, RTEL, TERT, etc., were linked to the risk and prognosis of glioma.–
Introduction:
Glioma, originated from glial or precursor cells, is the main pathological subtype of brain tumors, taking up about % of primary malignant brain tumors in human. Gliomas include astrocytoma, oligodendroglioma and ependymoma. According to their clinicopathological features, gliomas can be divided into grades I–IV, thereinto, grade IV glioma is also called glioblastoma multiforme. Despite great advances in glioma diagnosis, the number of gliomas remains increasing. In , it was reported that ,, cases of brain and…
Read more